Investigational drugs; expanded access. (HB1750)

Introduced By

Del. Margaret Ransone (R-Kinsale) with support from 17 copatrons, whose average partisan position is:

Those copatrons are Del. Dave Albo (R-Springfield), Del. Mark Cole (R-Fredericksburg), Del. Gordon Helsel (R-Poquoson), Del. Patrick Hope (D-Arlington), Del. Bill Howell (R-Fredericksburg), Del. Matthew James (D-Portsmouth), Del. Mark Keam (D-Vienna), Del. Randy Minchew (R-Leesburg), Del. Bobby Orrock (R-Thornburg), Del. John O'Bannon (R-Richmond), Del. Chris Peace (R-Mechanicsville), Del. David Ramadan (R-South Riding), Del. Roxann Robinson (R-Chesterfield), Del. Mark Sickles (D-Alexandria), Del. Chris Stolle (R-Virginia Beach), Del. Tony Wilt (R-Harrisonburg), Sen. Todd E. Pillion (R-Abingdon)

Progress

Introduced
Passed Committee
Passed House
Passed Senate
Signed by Governor
Became Law

Description

Expanded access to investigational drugs, biological products, and devices. Provides that a manufacturer of an investigational drug, biological product, or device may make such investigational drug, biological product, or device available to a person who has a terminal illness when (i) no comparable or satisfactory alternative treatment options approved by the U.S. Food and Drug Administration are available to treat his terminal illness; (ii) the potential benefits of the use of the investigational drug, biological product, or device outweigh the risks of use of the investigational drug, biological product, or device; (iii) his treating physician has recommended use of the investigational drug, biological product, or device; and (iv) the person has provided informed written consent to use of the investigational drug, biological product, or device. The bill provides that a manufacturer that provides an investigational drug, biological product, or device for treatment of a person's terminal illness may provide the investigational drug, biological product, or device free of charge or may require the person to pay costs associated with manufacture of the investigational drug, biological product, or device. The bill also provides that health insurance providers may, but are not required to, provide coverage for costs associated with use of the investigational drug, biological product, or device. Read the Bill »

Outcome

Bill Has Passed

History

DateAction
01/12/2015Committee
01/12/2015Prefiled and ordered printed; offered 01/14/15 15100033D
01/12/2015Referred to Committee on Health, Welfare and Institutions
01/20/2015Assigned HWI sub: Subcommittee #1
01/26/2015Subcommittee recommends reporting with amendment(s) (11-Y 0-N)
01/28/2015Impact statement from VDH (HB1750)
01/29/2015Reported from Health, Welfare and Institutions with amendments (22-Y 0-N) (see vote tally)
01/30/2015Read first time
02/02/2015Read second time
02/02/2015Committee amendments agreed to
02/02/2015Engrossed by House as amended HB1750E
02/02/2015Printed as engrossed 15100033D-E
02/03/2015Impact statement from VDH (HB1750E)
02/03/2015Read third time and passed House BLOCK VOTE (98-Y 0-N)
02/03/2015VOTE: BLOCK VOTE PASSAGE (98-Y 0-N) (see vote tally)
02/04/2015Constitutional reading dispensed
02/04/2015Referred to Committee on Education and Health
02/19/2015Reported from Education and Health with substitute (14-Y 0-N) (see vote tally)
02/19/2015Committee substitute printed 15105265D-S1
02/20/2015Impact statement from VDH (HB1750S1)
02/20/2015Constitutional reading dispensed (38-Y 0-N) (see vote tally)
02/23/2015Read third time
02/23/2015Reading of substitute waived
02/23/2015Committee substitute agreed to 15105265D-S1
02/23/2015Passed by for the day
02/24/2015Read third time
02/24/2015Engrossed by Senate - committee substitute HB1750S1
02/24/2015Passed Senate with substitute (39-Y 0-N) (see vote tally)
02/24/2015Placed on Calendar
02/25/2015Senate substitute agreed to by House 15105265D-S1 (98-Y 0-N)
02/25/2015VOTE: ADOPTION (98-Y 0-N) (see vote tally)
03/06/2015Enrolled
03/06/2015Bill text as passed House and Senate (HB1750ER)
03/06/2015Impact statement from VDH (HB1750ER)
03/06/2015Signed by Speaker
03/07/2015Signed by President
03/10/2015Enrolled Bill communicated to Governor on 3/10/15
03/10/2015G Governor's Action Deadline Midnight, Sunday, March 29, 2015
03/26/2015G Approved by Governor-Chapter 656 (effective 7/1/15)
03/26/2015G Acts of Assembly Chapter text (CHAP0656)

Video

This bill was discussed on the floor of the General Assembly. Below is all of the video that we have of that discussion, 2 clips in all, totaling 2 minutes.